Related Experiment Video

Updated: Aug 2, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

A rationale for gene targeting in glaucoma therapy

M Wax1, R Patil

  • 1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.

Journal of Ocular Pharmacology
|January 1, 1994
PubMed

Insights

New gene transfer techniques offer targeted glaucoma treatment by regulating aqueous humor production. This approach aims to reduce side effects associated with current medications like beta-adrenergic antagonists.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Glaucoma treatment often involves drugs reducing aqueous humor secretion.
  • Current medications, like beta-adrenergic antagonists, carry significant systemic side effects.
  • Understanding the ciliary epithelium's secretory process is crucial for developing safer treatments.

Purpose of the Study:

  • To propose genetic approaches for regulating gene expression in the ciliary epithelium.
  • To specifically target aqueous humor production for glaucoma management.
  • To explore novel therapeutic strategies with reduced morbidity and mortality.

Main Methods:

  • Discussing gene transfer techniques for targeted gene expression regulation.
  • Exploring homologous exchange recombination for precise genetic modification.
  • Investigating the use of antisense genes to modulate cellular function.

Main Results:

  • The study presents a rationale for using genetic approaches in glaucoma therapy.
  • It highlights the potential for specifically targeting aqueous humor production.
  • The proposed methods aim to overcome limitations of current pharmacological treatments.

Conclusions:

  • Genetic regulation of ciliary epithelium function offers a promising avenue for glaucoma treatment.
  • Gene transfer techniques provide a means to develop safer and more effective aqueous suppressants.
  • Further research into cellular mechanisms can lead to improved patient outcomes.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...